EMA Application withdrawn: Epixram — Neuraxpharm Pharmaceuticals S.L.

View source ↗

Summary

The European Medicines Agency has withdrawn the marketing authorization application for Epixram by Neuraxpharm Pharmaceuticals S.L., related to epilepsy indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Juvenile Myoclonic Epilepsy

Drugs mentioned

• Epixram

Snippet

Status: Application withdrawn. Therapeutic area: Epilepsy;Epilepsy, Generalized;Myoclonic Epilepsy, Juvenile. MAH: Neuraxpharm Pharmaceuticals S.L.